Atlas Trials

HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen

Clinical trial NCT02776202 · UNKNOWN

Trial details

NCT number
NCT02776202
Sponsor
National Guard Health Affairs
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2016-05-01
Primary completion
2019-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.